TNF and neoplasm: To precisely define the HLA restriction and to establish the distribution of the target antigen, we tested M314.132 reactivity towards various tumor cell lines, including melanomas, colon carcinomas, breast carcinomas, renal carcinomas, ovarian carcinomas, lung carcinomas and myelomas, using a TNF-release assay.